Medicine
Moexipril 15 mg tablet
Moexipril 15 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Moexipril
- Brand
- Sold under the generic name
- Strength
- 15 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 90 tablets and 2 more
- Manufacturers
- Glenmark PharmaceuticalsIndiaChartwell RXTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09AA13 Moexipril
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 May 2003
- Identifiers
- RxCUI 1299896, 1299897DailyMed set ID 5d4078f3-b621-475f-a4e6-005de2e62b32, 5c24072c-9769-4cb5-b8da-bf814d21391d, baac91ad-f8ee-4694-89f8-5c47a8eda39aNDC 0093-5150, 62135-969, 68462-208Application ANDA076204, ANDA077536, ANDA090416
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 68462-208-01 | Glenmark PharmaceuticalsIndia | 31 December 2010 |
| 1000 tablet, film coated in 1 bottle | 68462-208-10 | Glenmark PharmaceuticalsIndia | 31 December 2010 |
| 90 tablet, film coated in 1 bottle | 68462-208-90 | Glenmark PharmaceuticalsIndia | 31 December 2010 |
| 90 tablet, film coated in 1 bottle | 62135-969-90 | Chartwell RX | 5 March 2025 |
| 100 tablet, film coated in 1 bottle | 0093-5150-01 | Teva Pharmaceuticals | 8 May 2003 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 April 1995 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Moexipril
Clinical summary
Moexipril is an angiotensin converting enzyme inhibitor indicated for treatment of patients with hypertension. It is available as tablets for oral use. MedsAcross supplies Moexipril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MoexiprilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Moexipril Hydrochloride prescribing information (Glenmark Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Moexipril 15 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.